PT Semen Indonesia (Persero) Tbk (IDX:SMGR)

Theseus Pharmaceuticals Revenue

PT Semen Indonesia (Persero) Tbk had revenue of 7.95T IDR in the quarter ending June 30, 2025, a decrease of -1.02%. This brings the company's revenue in the last twelve months to 35.38T, down -6.96% year-over-year. In the year 2024, PT Semen Indonesia (Persero) Tbk had annual revenue of 36.19T, down -6.38%.

• Revenue (ttm): 35.38T
• Revenue Growth: -6.96%
• P/S Ratio: 0.48
• Revenue / Employee: 3.79B
• Employees: 9,405
• Market Cap: 16.81T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	36.19T	-2,465.23B	-6.38%
Dec 31, 2023	38.65T	2,272.76B	6.25%
Dec 31, 2022	36.38T	-323.70B	-0.88%
Dec 31, 2021	36.70T	1,530.63B	4.35%
Dec 31, 2020	35.17T	-5,196.44B	-12.87%